Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients

Anaesthesia and Intensive Care

Volumn 24, Issue 5, 1996, Pages 585-589

  Jan, G S K ^a   Tong, W N ^a   Chan, A M H ^a   Hui, T W C ^a   Lo, J W R ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Anaesthesia: obstetric; Anaesthetics, intravenous: mivacurium infusion, recovery, eostigmine

Indexed keywords

ATROPINE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; ENFLURANE; MIVACURIUM; NEOSTIGMINE; NITROUS OXIDE; PETHIDINE; SUXAMETHONIUM;

ADULT; ANESTHETIC RECOVERY; ARTICLE; CESAREAN SECTION; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; OBSTETRIC ANESTHESIA; RANDOMIZED CONTROLLED TRIAL; ULNAR NERVE;

EID: 0029860643     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9602400514     Document Type: Article

References (23)

1. Savarese JJ. Mivacurium. A comparison with other benzylisoquinolinium non-depolarising muscle relaxants. J Drug Dev 1993; 5(Suppl. 1):1-5.
2. Savarese JJ, Ali HH, Basta SJ, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesthesiology 1988; 68:723-732.
3. Ali HH, Savarese JJ, Embree PB, et al. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: Comparison with vecuronium and atracurium. Br J Anaesth 1988; 61(5):541-546.
4. Caldwell JE, Heier T, Kitts JB, Lynam DP, Fahey MR, Miller RD. Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia. Br J Anaesth 1989; 4:393-399.
5. Saitoh Y, Nakazawa K, Toyooka H, Amaha K. Optimal stimulating current for train-of-four stimulation in conscious subjects. Can J Anaesth 1995; 42(11):992-995.
6. Devcic A, Munshi CA, Gandhi SK, Kampine JP. Antagonism of mivacurium neuromuscular block: Neostigmine versus edrophonium. Anesth Analg 1995; 81:1005-1009.
7. Naguib M, Abdulatif M, Al-Ghamdi A, Hamo I, Nouheid R. Dose-response relationship for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. Br J Anaesth 1993; 71:709-714.
8. Whittaker M. Plasma cholinesterase variants and the anaesthetist (Review). Anaesthesia 1980; 35:174-197.
9. Blitt CD, Petty WC, Alberternst EE, Wright BJ. Correlation of plasmacholinesterase activity and duration of action of succinylcholine during pregnancy. Anesth Analg 1977; 56:78- 83.
10. Shnider SM. Serum cholinesterase activity during pregnancy, labour and the puerperium. Anesthesiology 1965; 26:335-339.
11. Leighton BL, Cheek TG, Gross JB, et al. Succinylcholine pharmacodynamics in peripartum patients. Anesthesiology 1986; 64:202-205.
12. Ravindran RS, Cummins DF, Pantazis KL, Strausburg BJ, Baenziger J. Unusal aspects of low levels of pseudocholinesterase in a pregnant patient. Anesth Analg 1982; 61:953-955.
13. Cambell MJ, Julious SA, Altman DG. Estimating sample size for binary, ordered categorised and continuous outcomes in two group comparisons. Br Med J 1995; 311:1145-1148.
14. Kao YJ, Le N, Barker SJ. Neostigmine prolongs profound neuromuscular blockade induced by mivacurium in surgical patients (Abstract) Anesthesiology 1993; 79:A929.
15. Maddineni VR, Mirakhur RK, McCoy EP. Recovery of mivacurium block with or without anticholinesterase following administration by continuous infusion. Anaesthesia 1994; 49:946-948.
16. De Mey JC, Fonck K, Mareels K, Roily G. The influence of isoflurane on a continuous infusion of mivacurium. Anaesthesia 1995; 50:947-949.
17. Platt MW. Mivacurium in day-case surgery. J Drug Dev 1993; 5(Suppl 1):15-19.
18. Goldhill DR, Whitehead JP, Emmott RS, Griffith AP, Bracey BJ, Flynn PJ. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia. Br J Anaesth 1991; 67(3):289-295.
19. From RR Pearson KS, Choi WW, Abou-Donia M, Sokoll MD. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B1090U) during nitrous oxide-fentanylthiopentone and nitrous oxide-halothane anaesthesia. Br J Anaesth 1990; 64(2):193-198.
20. Loan PB, Paxton LD, Mirakhur RK, Connolly FM, McCoy EP. The TOF-guard neuromuscular transmission monitor, a comparison with the myograph 2000. Anaesthesia 1995; 50:699-702.
21. Bevan DR, Donati F, Kopman AF. Reversal of neuromuscular blockade. (Review). Anesthesiology 1992; 77:785-805.
22. Lerman J. Study design in clinical research: sample size estimation and power analysis. Can J Anaesth 1996; 43(2):184-191.
23. Delvin JC, Head-Rapson AG, Parker CJR, Hunter JM. Pharmacology of mivacurium chloride in patients with hepatic cirrhosis. Br J Anaesth 1993; 71:227-231.